BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23337891)

  • 1. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
    Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
    J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
    Huang L; Zhang J; Chen F; Zhang X; Cao Y; Cheng R; Deng D
    J Dermatol; 2022 Sep; 49(9):921-924. PubMed ID: 35567308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phacomatosis Pigmentokeratotica: A Mosaic RASopathy with Malignant Potential.
    Om A; Cathey SS; Gathings RM; Hudspeth M; Lee JA; Marzolf S; Wine Lee L
    Pediatr Dermatol; 2017 May; 34(3):352-355. PubMed ID: 28523882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phacomatosis pigmentokeratotica is a "pseudodidymosis".
    Happle R
    J Invest Dermatol; 2013 Aug; 133(8):1923-5. PubMed ID: 23856930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratotica.
    Li JY; Berger MF; Marghoob A; Bhanot UK; Toyohara JP; Pulitzer MP
    J Cutan Pathol; 2014 Aug; 41(8):663-71. PubMed ID: 24628623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phacomatosis pigmentokeratotica: Postzygotic HRAS mutation with malignant degeneration of the sebaceous naevus.
    Cranwell WC; Walsh M; Winship I
    Australas J Dermatol; 2019 Aug; 60(3):e245-e246. PubMed ID: 30767209
    [No Abstract]   [Full Text] [Related]  

  • 7. Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma.
    Prieto-Barrios M; Llamas-Martin R; Velasco-Tamariz V; Calleja-Algarra A; Ruano Y; Ortiz-Romero PL; Rodriguez-Peralto JL
    Br J Dermatol; 2018 Nov; 179(5):1163-1167. PubMed ID: 29430633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
    Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
    Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
    Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
    Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absence of BRAF, FGFR3, and PIK3CA mutations differentiates lentigo simplex from melanocytic nevus and solar lentigo.
    Hafner C; Stoehr R; van Oers JM; Zwarthoff EC; Hofstaedter F; Klein C; Landthaler M; Hartmann A; Vogt T
    J Invest Dermatol; 2009 Nov; 129(11):2730-5. PubMed ID: 19536147
    [No Abstract]   [Full Text] [Related]  

  • 11. Papular nevus spilus syndrome: old and new aspects of a mosaic RASopathy.
    Torchia D; Happle R
    Eur J Dermatol; 2019 Feb; 29(1):2-5. PubMed ID: 30827948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent activating HRAS mutations in trichilemmoma.
    Tsai JH; Huang WC; Jhuang JY; Jeng YM; Cheng ML; Chiu HY; Kuo KT; Liau JY
    Br J Dermatol; 2014 Nov; 171(5):1073-7. PubMed ID: 24890286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HRAS mutation in phacomatosis pigmentokeratotica without extracutaneous disease.
    Jennings L; Cummins R; Murphy GM; Gulmann C; O'Kane M
    Clin Exp Dermatol; 2017 Oct; 42(7):791-792. PubMed ID: 28736904
    [No Abstract]   [Full Text] [Related]  

  • 14. Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation.
    Martin RJ; Arefi M; Splitt M; Redford L; Moss C; Rajan N
    Br J Dermatol; 2018 Jan; 178(1):289-291. PubMed ID: 28489335
    [No Abstract]   [Full Text] [Related]  

  • 15. Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver.
    Saraggi D; Salmaso R; Valentini E; Munari G; Vindigni V; Rugge M; Fassan M; Cerroni L
    Pathol Res Pract; 2017 Jul; 213(7):860-862. PubMed ID: 28554764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
    Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
    J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
    Sarin KY; Sun BK; Bangs CD; Cherry A; Swetter SM; Kim J; Khavari PA
    JAMA Dermatol; 2013 Sep; 149(9):1077-81. PubMed ID: 23884457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Phacomatosis Pigmentokeratotica as the Expression of a Mosaic RASopathy With the BRAF-Glu586Lys Mutation.
    Ayala D; Ramón MD; Martín JM; Jordá E
    Actas Dermosifiliogr; 2016 May; 107(4):344-6. PubMed ID: 26703821
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic analyses of a secondary poroma and trichoblastoma in a HRAS-mutated sebaceous nevus.
    Minowa T; Kamiya T; Hida T; Okura M; Kato J; Idogawa M; Tange S; Hirano T; Tokino T; Uhara H
    J Dermatol; 2021 Aug; 48(8):1268-1272. PubMed ID: 33908086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocytic epidermal nevi are associated with mosaic RAS mutations.
    Hafner C; Toll A; Gantner S; Mauerer A; Lurkin I; Acquadro F; Fernández-Casado A; Zwarthoff EC; Dietmaier W; Baselga E; Parera E; Vicente A; Casanova A; Cigudosa J; Mentzel T; Pujol RM; Landthaler M; Real FX
    J Med Genet; 2012 Apr; 49(4):249-53. PubMed ID: 22499344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.